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Aim
1) To raise awareness of the need to make trials more
efficient and 2) To hear delegates’ views on more colla-
borative trial methodology research.
Background
Doing a trial can be a challenge but do we make it a
greater challenge than it needs to be? For example, is the
research question the one most relevant to patients, health
professionals and policymakers? Do we really need to col-
lect all those data? Is selecting that site a good idea and
why? Do we know our retention strategies are effective
and if not, why are we using them without evaluation?
Changing the status quo
In this talk I’ll suggest that we rethink the way we do
trials. We are unlikely to find a magic bullet that will
make trials easy. We could, however, make trials more
efficient by being more sceptical of what we do and start
to systematically identify discrete trial processes, ask our-
selves why we do them, collate what is known about the
best ways to achieve this and then develop collaborative
programs of methodological work to address any knowl-
edge gaps. This, together with effective programs of dis-
semination to those designing, governing, running and
using trials, is more likely to lead to step-changes in trial
efficiency than a series of high quality, but uncoordi-
nated, methodological studies.
Conclusion
There is a tendency to do trials the way we do because
that’s the way we do them. We should work together to
make our trial processes more evidence-based.
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